Anticancer activity of VDR-coregulator inhibitor PS121912-Reference-Cited by-同舟云学术

Anticancer activity of VDR-coregulator inhibitor PS121912

Published:2014-08-09 Issue:4 Volume:74 Page:787-798
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Sidhu Preetpal S.,Teske Kelly,Feleke Belaynesh,Yuan Nina Y.,Guthrie Margaret L.,Fernstrum Grant B.,Vyas Nishita D.,Han Lanlan,Preston Joshua,Bogart Jonathan W.,Silvaggi Nicholas R.,Cook James M.,Singh Rakesh K.,Bikle Daniel D.,Arnold Leggy A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-014-2549-y.pdf

Reference49 articles.

1. Eisman JA, Martin TJ, MacIntyre I, Moseley JM (1979) 1,25-dihydroxyvitamin-D-receptor in breast cancer cells. Lancet 2:1335–1336

2. Colston K, Colston MJ, Feldman D (1981) 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108:1083–1086

3. Savli H, Aalto Y, Nagy B, Knuutila S, Pakkala S (2002) Gene expression analysis of 1,25(OH)2D3-dependent differentiation of HL-60 cells: a cDNA array study. Br J Haematol 118:1065–1070

4. Swami S, Raghavachari N, Muller UR, Bao YP, Feldman D (2003) Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat 80:49–62

5. Krishnan AV, Shinghal R, Raghavachari N, Brooks JD, Peehl DM, Feldman D (2004) Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays. Prostate 59:243–251

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repositioning in thyroid cancer: from point mutations to gene fusions;Frontiers in Oncology;2024-05-08

2. Modulating vitamin D receptor–coregulator binding with small molecules;Feldman and Pike' s Vitamin D;2024

3. Antiproliferative and immunoregulatory actions of vitamin D derivatives on hematological malignancies;Feldman and Pike's Vitamin D;2024

4. Vitamin D in Triple-Negative and BRCA1-Deficient Breast Cancer—Implications for Pathogenesis and Therapy;International Journal of Molecular Sciences;2020-05-23

5. Alternative binding sites at the vitamin D receptor and their ligands;Molecular and Cellular Endocrinology;2019-04